Trials / Completed
CompletedNCT00695539
Rosuvastatin Efficacy and Safety Evaluation in Hypercholesterolaemic Patients
A Multi-centre, Open Label, Non-randomised, Non Interventional, 24 Weeks Study for the Efficacy and Safety of Rosuvastatin Following Its Administration in Real Life Clinical Practice in Greek Hypercholesterolaemic Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 810 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-arm, phase IV, open-label, prospective, non interventional study to evaluate the efficacy, tolerability and safety of rosuvastatin administered for 24 weeks in approximately 900 Greek subjects with hypercholesterolemia under normal clinical practice.
Conditions
Timeline
- Start date
- 2007-12-01
- Completion
- 2008-12-01
- First posted
- 2008-06-12
- Last updated
- 2009-10-05
Locations
6 sites across 1 country: Greece
Source: ClinicalTrials.gov record NCT00695539. Inclusion in this directory is not an endorsement.